1. Home
  2. BANR vs STOK Comparison

BANR vs STOK Comparison

Compare BANR & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banner Corporation

BANR

Banner Corporation

HOLD

Current Price

$62.72

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$31.74

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BANR
STOK
Founded
1890
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.9B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
BANR
STOK
Price
$62.72
$31.74
Analyst Decision
Buy
Strong Buy
Analyst Count
6
9
Target Price
$71.20
$33.11
AVG Volume (30 Days)
187.3K
859.1K
Earning Date
01-21-2026
11-04-2025
Dividend Yield
3.19%
N/A
EPS Growth
14.84
N/A
EPS
5.49
0.68
Revenue
$640,027,000.00
$205,632,000.00
Revenue This Year
$0.96
$430.24
Revenue Next Year
$7.48
N/A
P/E Ratio
$11.42
$46.36
Revenue Growth
7.86
1128.17
52 Week Low
$54.01
$5.35
52 Week High
$72.58
$38.69

Technical Indicators

Market Signals
Indicator
BANR
STOK
Relative Strength Index (RSI) 38.10 51.79
Support Level $66.40 $31.00
Resistance Level $67.95 $33.90
Average True Range (ATR) 1.08 1.67
MACD -0.53 -0.26
Stochastic Oscillator 2.35 17.61

Price Performance

Historical Comparison
BANR
STOK

About BANR Banner Corporation

Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: